291650 — Aptamer Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Market Cap
KR₩63bn
Enterprise Value
KR₩49bn
Revenue
KR₩4bn

Annual balance sheet for Aptamer Sciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24,209	34,722	23,737	17,474	21,692
Net Total Accounts Receivable
Net Total Receivables	183	604	481	1,059	2,528
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24,815	37,964	25,034	18,833	25,865
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,540	7,441	7,251	10,981	10,108
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	33,262	45,645	32,536	31,981	41,106
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	432	2,538	15,239	3,895	11,771
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,800	16,423	17,057	6,545	12,875
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	31,461	29,223	15,479	25,436	28,231
Total Liabilities & Shareholders' Equity	33,262	45,645	32,536	31,981	41,106
Total Common Shares Outstanding
Total Preferred Shares Outstanding